Biogen Inc. Common Stock

BIIB Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
BIIB Income Statement
BIIB Balance Sheet
BIIB Cash Flow
Congress Trading

Recent trades of BIIB by members of U.S. Congress

Politician Type Traded
Daniel S. Goldman House / D Sale $1,001 - $15,000 Mar. 06, 2023
Shri Thanedar House / D Sale $15,001 - $50,000 Jan. 23, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Aug. 03, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 20, 2022
Josh Gottheimer House / D Sale $1,001 - $15,000 Mar. 17, 2022
Kathy E. Manning House / D Sale $1,001 - $15,000 Jan. 14, 2022
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jan. 10, 2022
Josh Gottheimer House / D Sale $1,001 - $15,000 Dec. 09, 2021
Josh Gottheimer House / D Purchase $1,001 - $15,000 Oct. 18, 2021
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep. 15, 2021
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jun. 08, 2021
Peter Meijer House / R Sale $15,001 - $50,000 Feb. 16, 2021
Chris Jacobs House / R Sale $1,001 - $15,000 Jan. 04, 2021
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 Dec. 22, 2020
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Sep. 16, 2020
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jul. 07, 2020
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Apr. 29, 2020
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 Mar. 18, 2020
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Feb. 07, 2020
Dean Phillips House / D Sale $1,001 - $15,000 Sep. 11, 2019
Dean Phillips House / D Sale $1,001 - $15,000 Aug. 13, 2019
Donna E. Shalala House / D Sale $1,001 - $15,000 Jun. 24, 2019
Dean Phillips House / D Purchase $1,001 - $15,000 Jun. 20, 2019
Dean Phillips House / D Sale $1,001 - $15,000 May. 13, 2019
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 May. 09, 2019
Nicholas V. Taylor House / R Sale $1,001 - $15,000 Mar. 25, 2019
Sheldon Whitehouse Senate / D Sale (Full) $1,001 - $15,000 Mar. 22, 2019
Josh Gottheimer House / D Sale $1,001 - $15,000 Oct. 29, 2018
Gary J. Palmer House / R Sale $1,001 - $15,000 Oct. 05, 2018
Gary J. Palmer House / R Purchase $1,001 - $15,000 Aug. 06, 2018
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jul. 24, 2018
Thomas MacArthur House / R Purchase $1,001 - $15,000 May. 02, 2018
Thomas MacArthur House / R Purchase $1,001 - $15,000 May. 02, 2018
Sheldon Whitehouse Senate / D Sale (Full) $1,001 - $15,000 Jan. 08, 2018
Gary J. Palmer House / R Purchase $1,001 - $15,000 Apr. 04, 2017
Lamar Smith House / R Sale $1,001 - $15,000 Mar. 29, 2017
Cheri Bustos House / D Sale $15,001 - $50,000 Jan. 30, 2017
Sheldon Whitehouse Senate / D Sale (Partial) $1,001 - $15,000 Dec. 23, 2016
Sheldon Whitehouse Senate / D Sale (Full) $15,001 - $50,000 Dec. 13, 2016
Thomas MacArthur House / R Purchase $1,001 - $15,000 Dec. 08, 2016
Thomas MacArthur House / R Purchase $1,001 - $15,000 Dec. 08, 2016
James M. Inhofe Senate / R Sale (Full) $50,001 - $100,000 Jul. 21, 2016
Ed Whitfield House / R Sale $1,001 - $15,000 Jun. 03, 2016
Ed Whitfield House / R Sale $1,001 - $15,000 Apr. 13, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 Apr. 01, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 Apr. 01, 2016
Ed Whitfield House / R Purchase $1,001 - $15,000 Feb. 04, 2016
Thomas MacArthur House / R Sale $50,001 - $100,000 Feb. 02, 2016
Ed Whitfield House / R Purchase $1,001 - $15,000 Jan. 25, 2016
Ed Whitfield House / R Purchase $1,001 - $15,000 Jan. 19, 2016
BIIB Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
BIIB Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
BIIB Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by BIIB's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $710,000 Oct 19, 2024 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $1,670,000 Jul 22, 2024 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $1,060,000 Apr 22, 2024 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $830,000 Feb 13, 2024 Issue: Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $940,000 Jan 21, 2024 Issue: Transportation Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $1,090,000 Oct 19, 2023 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $900,000 Jan 20, 2023 Issue: Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $940,000 Nov 08, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $900,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $1,060,000 Apr 19, 2022 Issue: Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
  • $670,000 Jan 20, 2022 Issue: None
  • $910,000 Oct 19, 2021 Issue: None
  • $980,000 Jul 19, 2021 Issue: None
  • $1,570,000 Apr 20, 2021 Issue: None
  • $890,000 Jan 21, 2021 Issue: None
  • $1,150,000 Oct 19, 2020 Issue: None
  • $760,000 Jul 20, 2020 Issue: None
  • $1,090,000 Apr 20, 2020 Issue: None
  • $266,680 Jan 22, 2020 Issue: None
  • $560,000 Oct 21, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $280,000 Jul 22, 2019 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
  • $810,000 Apr 22, 2019 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $790,000 Jan 22, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $810,000 Oct 22, 2018 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark
  • $890,000 Jul 18, 2018 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues
  • $730,000 Apr 19, 2018 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $590,000 Jan 18, 2018 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $640,000 Oct 17, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $710,000 Jul 17, 2017 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid
  • $740,000 Apr 18, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $630,000 Jan 18, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $710,000 Oct 19, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $730,000 Jul 19, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $620,000 Apr 20, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $540,000 Jan 19, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $570,000 Oct 19, 2015 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Medicare/Medicaid Taxation/Internal Revenue Code
  • $580,000 Jul 20, 2015 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $540,000 Apr 20, 2015 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid
  • $430,000 Jan 16, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $460,000 Oct 19, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $405,000 Jul 21, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $405,000 Apr 18, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $395,000 Jan 16, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $395,000 Oct 17, 2013 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
  • $435,000 Jul 22, 2013 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $400,000 Apr 22, 2013 Issue: Health Issues Trade (domestic/foreign) Medicare/Medicaid Taxation/Internal Revenue Code
  • $360,000 Jan 22, 2013 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
  • $415,000 Oct 19, 2012 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $440,000 Jul 18, 2012 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Trade (domestic/foreign)
  • $445,000 Apr 19, 2012 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $520,000 Jan 18, 2012 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $480,000 Oct 20, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $390,000 Jul 20, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $420,000 Apr 18, 2011 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
  • $335,000 Jan 20, 2011 Issue: Medicare/Medicaid Copyright/Patent/Trademark Health Issues Taxation/Internal Revenue Code
  • $365,000 Oct 19, 2010 Issue: Health Issues Copyright/Patent/Trademark Medicare/Medicaid Taxation/Internal Revenue Code
  • $240,000 Jul 20, 2010 Issue: Copyright/Patent/Trademark Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $290,000 Apr 19, 2010 Issue: Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid
  • $290,000 Jan 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $350,000 Oct 19, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
  • $300,000 Jul 28, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $290,000 Apr 20, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
  • $170,000 Jan 16, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $180,000 Oct 16, 2008 Issue: Medicare/Medicaid Copyright/Patent/Trademark Health Issues
  • $180,000 Oct 16, 2008 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $200,000 Apr 18, 2008 Issue: Health Issues Copyright/Patent/Trademark Medicare/Medicaid
  • $620,000 Feb 13, 2008 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid
  • $620,000 Aug 13, 2007 Issue: Health Issues Copyright/Patent/Trademark
  • $281,000 Feb 14, 2007 Issue: Health Issues Medicare/Medicaid
  • $286,000 Aug 11, 2006 Issue: Medicare/Medicaid Pharmacy Health Issues
  • $380,000 Feb 14, 2006 Issue: Medicare/Medicaid
  • $510,000 Oct 27, 2005 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
  • $430,000 Sep 06, 2005 Issue: Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code Health Issues
  • $370,000 Jun 21, 2004 Issue: Medicare/Medicaid Health Issues
  • $420,000 Jun 21, 2004 Issue: None
  • $60,000 Oct 22, 2003 Issue: Medicare/Medicaid
  • $50,000 Aug 25, 2003 Issue: Medicare/Medicaid
  • $60,000 Aug 13, 2003 Issue: Health Issues Medicare/Medicaid
  • $80,000 Aug 04, 2003 Issue: Retirement Health Issues Medicare/Medicaid
  • $60,000 Aug 01, 2003 Issue: None
  • $66,490 Jul 17, 2003 Issue: Health Issues
  • $30,000 Jun 11, 2003 Issue: None
  • $44,569 Mar 14, 2003 Issue: Health Issues
  • $20,000 Feb 25, 2003 Issue: Budget/Appropriations
  • $60,000 Feb 24, 2003 Issue: Medicare/Medicaid
  • $60,000 Feb 14, 2003 Issue: Health Issues Medicare/Medicaid
  • $100,000 Feb 14, 2003 Issue: Retirement Health Issues Medicare/Medicaid
  • $20,000 Feb 06, 2003 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid
  • $40,000 Feb 04, 2003 Issue: Budget/Appropriations
  • $60,000 Aug 19, 2002 Issue: Budget/Appropriations
  • $100,000 Aug 19, 2002 Issue: Medicare/Medicaid Insurance
  • $60,000 Aug 14, 2002 Issue: Health Issues
  • $60,000 Aug 14, 2002 Issue: Medicare/Medicaid
  • $60,000 Aug 13, 2002 Issue: Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $80,000 Aug 13, 2002 Issue: Retirement Health Issues Medicare/Medicaid
  • $60,000 Mar 12, 2002 Issue: Medicare/Medicaid Pharmacy
  • $40,000 Mar 01, 2002 Issue: Budget/Appropriations
  • $25,000 Feb 14, 2002 Issue: Health Issues
  • $60,000 Feb 07, 2002 Issue: Health Issues Medicare/Medicaid Copyright/Patent/Trademark
  • $350,000 Aug 14, 2001 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Methods of treating a multiple sclerosis patient with anti-vla-4 therapy Oct. 01, 2024
  • Patent Title: Compositions for modulating tau expression Sep. 17, 2024
  • Patent Title: Method of assessing risk of pml Aug. 20, 2024
  • Patent Title: Anti-vla-4 antibodies having reduced effector function Jul. 16, 2024
  • Patent Title: Method of assessing risk of pml Jul. 09, 2024
  • Patent Title: Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications Jun. 25, 2024
  • Patent Title: Compositions and methods for detection of smn protein in a subject and treatment of a subject Jun. 18, 2024
  • Patent Title: Ask1 inhibiting agents Jun. 04, 2024
  • Patent Title: Pyridine macrocycle compounds as ask1 inhibiting agents Feb. 13, 2024
  • Patent Title: Inhibiting agents for bruton's tyrosine kinase Jan. 02, 2024
  • Patent Title: Methods for improved measurements of brain volume and changes in brain volume Dec. 26, 2023
  • Patent Title: Drug for treating or preventing cerebral hemorrhage, and method for treating or preventing cerebral hemorrhage using the drug Dec. 26, 2023
  • Patent Title: Arginine-free tnfr:fc-fusion polypeptide compositions Dec. 05, 2023
  • Patent Title: Anti-transferrin receptor antibodies and uses thereof Nov. 28, 2023
  • Patent Title: Crystalline polymorphs of bruton's tyrosine kinase inhibitors Nov. 21, 2023
  • Patent Title: Ask1 inhibiting agents Nov. 14, 2023
  • Patent Title: Copper supplementation for control of glycosylation in mammalian cell culture process Sep. 12, 2023
  • Patent Title: Method for distribution of a drug Jul. 11, 2023
  • Patent Title: Methods for purifying antibodies having reduced high molecular weight aggregates Jul. 11, 2023
  • Patent Title: Methods and products for evaluating an immune response to a therapeutic protein Jun. 27, 2023
  • Patent Title: Medical diagnostic and treatment systems and their methods of use May. 30, 2023
  • Patent Title: Pharmaceutical compositions containing anti-beta amyloid antibodies May. 23, 2023
  • Patent Title: Crm1 inhibitors for treating epilepsy Mar. 14, 2023
  • Patent Title: Compositions for modulating tau expression Feb. 28, 2023
  • Patent Title: Biaryl inhibitors of bruton's tyrosine kinase Feb. 07, 2023
  • Patent Title: Anti-vla-4 antibodies Feb. 07, 2023
  • Patent Title: Cytoprotective agent Jan. 03, 2023
  • Patent Title: Compositions and methods for modulation of smn2 splicing in a subject Dec. 27, 2022
  • Patent Title: Assessment of labeled probes in a subject Nov. 01, 2022
  • Patent Title: Tetrahydronaphthalene derivatives useful as nrf2 activators Oct. 11, 2022
  • Patent Title: O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitors Oct. 04, 2022
  • Patent Title: Bispecific antibody platform Sep. 20, 2022
  • Patent Title: Inhibiting agents for bruton's tyrosine kinase Aug. 30, 2022
  • Patent Title: Irak4 inhibiting agents Aug. 30, 2022
  • Patent Title: Methods for improved measurements of brain volume and changes in brain volume Jul. 12, 2022
  • Patent Title: Methods of treating inflammatory and autoimmune diseases with natalizumab May. 17, 2022
  • Patent Title: Pegylation method May. 03, 2022
  • Patent Title: Nuclear transport modulators and uses thereof May. 03, 2022
  • Patent Title: Methods of treating inflammatory and autoimmune diseases with natalizumab Apr. 05, 2022
  • Patent Title: Hybrid actriib ligand trap proteins for treating muscle wasting diseases Apr. 05, 2022
  • Patent Title: Dimethyl fumarate particles and pharmaceutical compositions thereof Apr. 05, 2022
  • Patent Title: Assay for jc virus antibodies Mar. 29, 2022
  • Patent Title: Method of assessing risk of pml Mar. 22, 2022
  • Patent Title: Anti-vla-4 related assays Mar. 22, 2022
  • Patent Title: Copper supplementation for control of glycosylation in mammalian cell culture process Mar. 08, 2022
  • Patent Title: Use of raman spectroscopy to monitor culture medium Feb. 15, 2022
  • Patent Title: Administration of agents for the treatment of inflammation Feb. 15, 2022
  • Patent Title: Methods of treating multiple sclerosis Feb. 15, 2022
  • Patent Title: Pharmaceutical bead formulations comprising dimethyl fumarate Dec. 14, 2021
  • Patent Title: Process for preparing alpha-carboxamide pyrrolidine derivatives Dec. 07, 2021
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of BIIB in WallStreetBets Daily Discussion

BIIB News

Recent insights relating to BIIB

CNBC Recommendations

Recent picks made for BIIB stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BIIB

BIIB Top Shareholders
Shareholder
Shares Held
BIIB Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

BIIB Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view BIIB Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top